Using a double transgenic mouse model overexpressing PTPROt and TCL1A, the same team that discovered TCL1A repression of PTPROt highlighted that PTPROt overexpression had a tumor suppressor effect in vivo, which had been previously identified in other studies [153,156]. The gene discussed is PTPRO; the disease is neoplasm.